Acceleration of Development Process
Accelerating drug discovery and development processes
through a GenAI-powered genome mining platform.
Paradigm Shift
Developing rapid and broad-spectrum therapeutics
that overcome the limitations of conventional vaccines against emerging viruses.
Securing Domestic &
Global Market Leadership
Establishing microbiome R&D capabilities and infrastructure
to provide innovative products and personalized healthcare solutions.
Minimizing Social Disruption
Minimizing social unrest caused by pandemics
through the rapid development of treatments for emerging infectious diseases.
Social Contribution
Contributing to global public health by addressing rotavirus-induced
infant infections in developing countries (Promoting Health ODA with UNICEF and WHO).
Market Growth
Expanding the medifood market through GenAI-driven functional materials
and generating high revenue through differentiated,
high-value-added innovative drug development.
Creating Future Growth Engines
Expanding global market share beyond the domestic market
by developing a diverse range of premium medifood products.
ESG Management
Promoting environmental protection and social responsibility
through sustainable ingredient sourcing and health improvement.